描述

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market is poised to grow by US$ 18.0 十亿来自 2022 到 2028, 复合年增长率为 4.5% 在预测期内, 根据StrategyHelix.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for biobanking. The global biobanking market is segmented on the basis of sample type, 类型, biobank format, ownership, 应用, 和地区. By sample type, the global biobanking market has been segmented into biofluids, DNA/RNA, stem cells, 组织, 其他的. The biofluids segment was the largest contributor to the global biobanking market in 2021. Based upon type, the global biobanking market is categorized into partnership, standalone. 据研究, the standalone segment had the largest share in the global biobanking market. On the basis of biobank format, the global biobanking market has been segmented into diseased-oriented biobanks, population-based biobanks. The diseased-oriented biobanks segment held the largest revenue share in 2021. By ownership, the global biobanking market has been segmented into national & regional agencies, universities, non-profit organization, private organization. 全球范围, the national & regional agencies segment made up the largest share of the biobanking market. Based on application, the global biobanking market is categorized into research, therapeutics. 从地理上来说, the global biobanking market has been segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排).

The global biobanking market is highly competitive. 作为 2021, the major players in the global biobanking market were All of Us, Auria Biobank, Biobank Graz, BioBank Japan (BBJ), Biobank VAST, China Kadoorie Biobank (CKB), China National GeneBank DataBase (CNGB), Danish National Biobank, deCODE genetics Inc., EuroBioBank, Kaiser Permanente Research Bank, National Liver Disease Biobank, NIGMS Human Genetic Cell Repository, The Cancer Human Biobank (caHUB), THL Biobank/Finnish Institute for Health and Welfare (THL), UK Biobank Limited, Uppsala Biobank. Competitive landscape gives a description of the competitive nature of the global biobanking market and a description of the leading companies. 确定了近年来塑造市场的关键金融交易.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the biobanking market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

Sample type: biofluids, DNA/RNA, stem cells, 组织, 其他的
类型: partnership, standalone
Biobank format: diseased-oriented biobanks, population-based biobanks
Ownership: 国家的 & regional agencies, universities, non-profit organization, private organization
应用: 研究, therapeutics
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028
提到的公司: All of Us, Auria Biobank, Biobank Graz, BioBank Japan (BBJ), Biobank VAST, China Kadoorie Biobank (CKB), China National GeneBank DataBase (CNGB), Danish National Biobank, deCODE genetics Inc., EuroBioBank, Kaiser Permanente Research Bank, National Liver Disease Biobank, NIGMS Human Genetic Cell Repository, The Cancer Human Biobank (caHUB), THL Biobank/Finnish Institute for Health and Welfare (THL), UK Biobank Limited, Uppsala Biobank

利益相关者的主要好处

– Get a comprehensive picture of the global biobanking market
– 根据当地数据确定区域战略和战略重点
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Biobanking market overview
部分 3. Market breakdown by sample type
– Biofluids
– DNA/RNA
– Stem cells
– Tissues
– 其他的
部分 4. Market breakdown by type
– Partnership
– Standalone
部分 5. Market breakdown by biobank format
– Diseased-oriented biobanks
– Population-based biobanks
部分 6. Market breakdown by ownership
– National & regional agencies
– Universities
– Non-profit organization
– Private organization
部分 7. 按应用划分的市场细分
– Research
– Therapeutics
部分 8. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 9. 重点企业
– All of Us
– Auria Biobank
– Biobank Graz
– BioBank Japan (BBJ)
– Biobank VAST
– China Kadoorie Biobank (CKB)
– China National GeneBank DataBase (CNGB)
– Danish National Biobank
– deCODE genetics, 公司.
– EuroBioBank
– Kaiser Permanente Research Bank
– National Liver Disease Biobank
– NIGMS Human Genetic Cell Repository
– The Cancer Human Biobank (caHUB)
– THL Biobank/Finnish Institute for Health and Welfare (THL)
– UK Biobank Limited
– Uppsala Biobank
关于StrategyHelix
免责声明